Clinical Trial Update: Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated thalidomide in combination with capecitabine in patients with metastatic breast cancer. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Thalidomide (thalidomide)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED